Astrana Health, Inc. (NASDAQ:ASTH) Short Interest Update

Astrana Health, Inc. (NASDAQ:ASTH) saw a large increase in short interest in November. As of November 30th, there was short interest totalling 1,640,000 shares, an increase of 5.1% from the November 15th total of 1,560,000 shares. Currently, 4.6% of the shares of the stock are short sold. Based on an average daily volume of 299,300 shares, the short-interest ratio is presently 5.5 days.

Wall Street Analyst Weigh In

ASTH has been the topic of a number of research reports. TD Cowen began coverage on shares of Astrana Health in a research note on Monday, October 14th. They set a “buy” rating and a $66.00 target price on the stock. Robert W. Baird boosted their price objective on Astrana Health from $67.00 to $86.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 13th. BTIG Research increased their target price on Astrana Health from $60.00 to $70.00 and gave the company a “buy” rating in a research report on Thursday, October 3rd. Finally, KeyCorp assumed coverage on Astrana Health in a research note on Friday, October 11th. They set a “sector weight” rating on the stock. One investment analyst has rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Buy” and an average price target of $65.17.

Astrana Health Trading Down 0.2 %

ASTH traded down $0.09 during midday trading on Tuesday, hitting $36.70. 8,970 shares of the company were exchanged, compared to its average volume of 212,057. The firm has a market capitalization of $2.06 billion, a P/E ratio of 28.30, a P/E/G ratio of 1.80 and a beta of 1.13. The firm’s 50 day moving average price is $49.04 and its 200-day moving average price is $48.12. The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.60. Astrana Health has a 1-year low of $34.11 and a 1-year high of $63.20.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings data on Thursday, November 7th. The company reported $0.33 EPS for the quarter, hitting analysts’ consensus estimates of $0.33. The company had revenue of $478.71 million for the quarter, compared to analyst estimates of $462.01 million. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. During the same period in the previous year, the firm earned $0.47 earnings per share. As a group, equities analysts forecast that Astrana Health will post 1.16 EPS for the current fiscal year.

Institutional Investors Weigh In On Astrana Health

Institutional investors have recently modified their holdings of the company. Franklin Resources Inc. acquired a new position in Astrana Health in the third quarter valued at $1,187,000. Hohimer Wealth Management LLC acquired a new position in shares of Astrana Health in the 3rd quarter valued at about $312,000. Geode Capital Management LLC acquired a new position in shares of Astrana Health in the 3rd quarter valued at about $58,995,000. Barclays PLC bought a new stake in shares of Astrana Health during the 3rd quarter valued at about $4,457,000. Finally, State Street Corp bought a new stake in Astrana Health in the third quarter worth approximately $91,966,000. 52.77% of the stock is owned by institutional investors.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.